CTLA4 antibody (AA 52-211)
Quick Overview for CTLA4 antibody (AA 52-211) (ABIN7426229)
Target
See all CTLA4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 52-211
-
Purpose
- Monoclonal Antibody to Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4)
-
Specificity
- The antibody is a mouse monoclonal antibody raised against CTLA4. It has been selected for its ability to recognize CTLA4 in immunohistochemical staining and western blotting.
-
Cross-Reactivity
- Pig, Rat
-
Purification
- Protein A + Protein G affinity chromatography
-
Immunogen
- Recombinant Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4) corresdonding to Gly52~Cys211 with N-terminal His Tag
-
Isotype
- IgG2b kappa
-
-
-
-
Application Notes
- Western blotting: 0.01-2 μg/mL,Immunohistochemistry: 5-20 μg/mL,Immunocytochemistry: 5-20 μg/mL,Optimal working dilutions must be determined by end user.
-
Comment
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
Preservative
- ProClin, Sodium azide
-
Precaution of Use
- This product contains ProClin and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
Expiry Date
- 24 months
-
-
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
-
Alternative Name
- CTLA4
-
Background
- CD152, CELIAC3, CTLA4, GSE, IDDM12, Celiac Disease 3, Cytotoxic T-lymphocyte protein 4
-
UniProt
- P16410
-
Pathways
- Cancer Immune Checkpoints
Target
-